documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
252 rows where docket_id = "EPA-HQ-OAR-2004-0074" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-HQ-OAR-2004-0074-0265 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Margo T. Oge, Director, Office of Mobile Sources, EPA to Donald R. Lynam, Ph.D, CIH, P.E., Vice President, Air Conservation Ethyl Corporation [A-98-35-III-A-1] | Supporting & Related Material | 2024-05-28T04:00:00Z | 2024 | 5 | 2024-05-28T14:38:49Z | 0 | 0 | 09000064846afb99 | ||||
| EPA-HQ-OAR-2004-0074-0262 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Merrylin Zaw-Mon, Director Transportation and Regional Programs Division [A-98-35-V-A-3] | Supporting & Related Material | Letter | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:49Z | 0 | 0 | 09000064846afc89 | |||
| EPA-HQ-OAR-2004-0074-0257 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Timothy D. Backstrom, ( EPA Counsel, to F. William Brownell, Esq. Hunton & William for Ethyl Corporation [A-98-35-III-B-1] | Supporting & Related Material | Letter | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:46Z | 0 | 0 | 09000064846afc84 | |||
| EPA-HQ-OAR-2004-0074-0256 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Federal Register of Tuesday, February 9, 1999 (64 FR 6394) (FRL-6231-91) [A-98-35-III-A-3] | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:46Z | 0 | 0 | 09000064846afc83 | |||
| EPA-HQ-OAR-2004-0074-0263 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Federal Register of Wednesday, July 19, 2000 (65 FR 44775) (FRL-6837-4) [A-98-35-V-A-4] | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:51Z | 0 | 0 | 09000064846afc8a | |||
| EPA-HQ-OAR-2004-0074-0264 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Characterization of Manganese Particulates from Vehicles Using MMT Fuel, A Compilation of Results from studies performed, by Lawrence Livermore National Laboratory Southwest Research Institute University of Minnesota Research Triangle Institute Ethyl Research and Developmen, September 10, 1997. [A-98-35-II-B-01] | Supporting & Related Material | Report | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:51Z | 0 | 0 | 09000064846afc8b | |||
| EPA-HQ-OAR-2004-0074-0255 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Deborah K. Wood, Acting Director Fuels and Energy Division,[A-98-35-III-A-2] | Supporting & Related Material | Letter | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:45Z | 0 | 0 | 09000064846afb9a | |||
| EPA-HQ-OAR-2004-0074-0261 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Margo T. Oge, Director, Office of Transportation and Air Quality, Donald R. Lynam, Ph.D., CIH, P.E. Vice President, Air Conservation Ethyl Corporation [A-98-35-V-A-2] | Supporting & Related Material | Letter | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:49Z | 0 | 0 | 09000064846afc88 | |||
| EPA-HQ-OAR-2004-0074-0259 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Timothy D. Backstrom, EPA Counsel to Kevin L. Fast, Esq. Hunton & Williams for Ethyl Corporation [A-98-35-III-B-3] | Supporting & Related Material | Letter | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:47Z | 0 | 0 | 09000064846afc86 | |||
| EPA-HQ-OAR-2004-0074-0260 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Margo T. Oge, Director, Office of Transportation and Air Quality to Donald R. Lynam, Ph.D., CIH, P.E. Vice President, Air Conservation Ethyl Corporation [A-98-35-V-A-1] | Supporting & Related Material | Letter | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:48Z | 0 | 0 | 09000064846afc87 | |||
| EPA-HQ-OAR-2004-0074-0258 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from Timothy D. Backstrom, ( EPA Counsel, to F. William Brownell, Esq. Hunton & William for Ethyl Corporation [A-98-35-III-B-2] | Supporting & Related Material | Letter | 2024-01-02T05:00:00Z | 2024 | 1 | 2024-01-02T14:49:47Z | 0 | 0 | 09000064846afc85 | |||
| EPA-HQ-OAR-2004-0074-0246 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Song - Addition Of Drinking Water To Rat And Human Mn PBPK Model Paper | Supporting & Related Material | Publication | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:14Z | 0 | 0 | 0900006484738ddb | |||
| EPA-HQ-OAR-2004-0074-0251 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Andersen Monkey Transporter Presentation 3.19.2020 | Supporting & Related Material | Meeting Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:16Z | 0 | 0 | 090000648478dc22 | |||
| EPA-HQ-OAR-2004-0074-0240 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Clewell Mn TAP PBPK Background | Supporting & Related Material | Meeting Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:10Z | 0 | 0 | 0900006484738a6d | |||
| EPA-HQ-OAR-2004-0074-0241 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Gentry - PBPK Model Applications | Supporting & Related Material | Meeting Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:11Z | 0 | 0 | 0900006484738a6e | |||
| EPA-HQ-OAR-2004-0074-0247 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Yoon - Mn PBPK Dev Drinking Water Paper (002) | Supporting & Related Material | Publication | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:14Z | 0 | 0 | 0900006484738ddd | |||
| EPA-HQ-OAR-2004-0074-0239 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | History of Manganese Modeling 2020 | Supporting & Related Material | Report | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:10Z | 0 | 0 | 0900006484738a6c | |||
| EPA-HQ-OAR-2004-0074-0250 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Andersen Mn Rat Transporter Model TAP 3.19.20 | Supporting & Related Material | Meeting Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:16Z | 0 | 0 | 090000648478d456 | |||
| EPA-HQ-OAR-2004-0074-0242 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Mn Margins of Safety Paper | Supporting & Related Material | Publication - Copyrighted Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:11Z | 0 | 0 | 0900006484738a6f | |||
| EPA-HQ-OAR-2004-0074-0245 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Foster Dorman - Rat Drinking Water Paper | Supporting & Related Material | Publication - Copyrighted Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:13Z | 0 | 0 | 0900006484738a72 | |||
| EPA-HQ-OAR-2004-0074-0236 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Chemical Corporation Letter transmitting availability of manganese PBPK models and Technical Advisory Panel meeting results | Supporting & Related Material | Letter | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:08Z | 0 | 0 | 0900006484738233 | |||
| EPA-HQ-OAR-2004-0074-0243 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Clewell - Drinking Water Models | Supporting & Related Material | Meeting Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:12Z | 0 | 0 | 0900006484738a70 | |||
| EPA-HQ-OAR-2004-0074-0237 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Report of the Technical Advisory Panel meeting for Manganese PBPK models - Meeting date: March 19, 2020 | Supporting & Related Material | Report | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:09Z | 0 | 0 | 0900006484738234 | |||
| EPA-HQ-OAR-2004-0074-0238 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Agenda for TAP Meeting | Supporting & Related Material | Meeting Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:09Z | 0 | 0 | 0900006484738235 | |||
| EPA-HQ-OAR-2004-0074-0249 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Clewell - Model Uncertainty Analysis | Supporting & Related Material | Meeting Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:15Z | 0 | 0 | 0900006484738de0 | |||
| EPA-HQ-OAR-2004-0074-0244 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Final Report - Pharmacokinetic Evaluation of the Equivalency of Oral Routes of Manganese Exposure in F344 Rats | Supporting & Related Material | Report | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:13Z | 0 | 0 | 0900006484738a71 | |||
| EPA-HQ-OAR-2004-0074-0248 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Yoon - Rat Transporter Paper | Supporting & Related Material | Publication - Copyrighted Materials | 2020-08-06T04:00:00Z | 2020 | 8 | 2020-08-06T17:42:15Z | 0 | 0 | 0900006484738dde | |||
| EPA-HQ-OAR-2004-0074-0234 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Analysis of Manganese Tracer Kinetics and Target Tissue Dosimetry in Monkeys and Humans with Multi-Route Physiologically Based Pharmacokinetic Models | Supporting & Related Material | Publication - Copyrighted Materials | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T19:55:51Z | 0 | 0 | 090000648149c798 | |||
| EPA-HQ-OAR-2004-0074-0235 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Physiologically Based Pharmacokinetic Modeling of Fetal and Neonatal Manganese Exposure in Humans: Describing Manganese Homeostasis during Development | Supporting & Related Material | Publication - Copyrighted Materials | 2013-12-04T05:00:00Z | 2013 | 12 | 2013-12-04T19:55:51Z | 0 | 0 | 090000648149c8a3 | |||
| EPA-HQ-OAR-2004-0074-0227 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Yoon Supplementary Data 1 | Supporting & Related Material | Data | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:02Z | 0 | 0 | 090000648149c8a4 | |||
| EPA-HQ-OAR-2004-0074-0223 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Chemical Letter EPA transmitting manganese PBPK models | Supporting & Related Material | Letter | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:02Z | 0 | 0 | 090000648149c732 | |||
| EPA-HQ-OAR-2004-0074-0233 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Response to the 10/31/2013 TAP Meeting from Hanmner | Supporting & Related Material | Letter | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:03Z | 0 | 0 | 090000648149cd2b | |||
| EPA-HQ-OAR-2004-0074-0230 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Yoon presentaton to TAP | Supporting & Related Material | Meeting Materials | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:03Z | 0 | 0 | 090000648149c8aa | |||
| EPA-HQ-OAR-2004-0074-0228 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Yoon Supplementary Data 2 | Supporting & Related Material | Data | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:03Z | 0 | 0 | 090000648149c8a5 | |||
| EPA-HQ-OAR-2004-0074-0229 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Yoon Supplementary Data 3 | Supporting & Related Material | Report | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:03Z | 0 | 0 | 090000648149c8a6 | |||
| EPA-HQ-OAR-2004-0074-0224 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Schroeter Presentation to TAP | Supporting & Related Material | Meeting Materials | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:02Z | 0 | 0 | 090000648149c79a | |||
| EPA-HQ-OAR-2004-0074-0225 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Schroeter Supplementary Data 1 | Supporting & Related Material | Data | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:02Z | 0 | 0 | 090000648149c79f | |||
| EPA-HQ-OAR-2004-0074-0226 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Schroeter Supplementary Data 2 | Supporting & Related Material | Data | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:02Z | 0 | 0 | 090000648149c7a0 | |||
| EPA-HQ-OAR-2004-0074-0231 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Agenda for Meeting of TAP | Supporting & Related Material | Meeting Materials | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:03Z | 0 | 0 | 090000648149c8ab | |||
| EPA-HQ-OAR-2004-0074-0232 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Report of the 10/31/2013 TAP Meeting | Supporting & Related Material | Report | 2013-12-03T05:00:00Z | 2013 | 12 | 2013-12-03T14:02:03Z | 0 | 0 | 090000648149c8ac | |||
| EPA-HQ-OAR-2004-0074-0222 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | The Hamner Institute for Health Sciences Presentation on use of Physiologically-based pharmacokinetic (PBPK) modeling to reduce uncertainty in risk assessment: Example of manganese. | Supporting & Related Material | Report | 2010-10-01T04:00:00Z | 2010 | 10 | 2010-10-01T16:39:08Z | 0 | 0 | 0900006480b6489c | |||
| EPA-HQ-OAR-2004-0074-0221 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Chemical Corporation letter describing proposed continuation of the Alternative Tier 2 reporting procedure to include development of the Mn PBPK models for humans | Supporting & Related Material | Letter, Memorandum, Email | 2009-08-19T04:00:00Z | 2009 | 8 | 2009-08-19T17:38:56Z | 0 | 0 | 0900006480a0d174 | |||
| EPA-HQ-OAR-2004-0074-0220 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Model Code for the Manganese Physiologically-Based Pharmcokinetic Gestation and Lactation Rat Model | Supporting & Related Material | Data | 2009-06-23T04:00:00Z | 2009 | 6 | 2009-06-23T14:13:08Z | 0 | 0 | 09000064809d2e22 | |||
| EPA-HQ-OAR-2004-0074-0219 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | EPA Memorandum Transmiting Comments on Review and Approval of the Manganese Physiologically-Based Pharmacokinetic Gestation and Lactation Rat Model | Supporting & Related Material | Letter, Memorandum, Email | 2009-06-19T04:00:00Z | 2009 | 6 | 2009-06-19T20:00:05Z | 0 | 0 | 09000064809d2e23 | |||
| EPA-HQ-OAR-2004-0074-0215 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Email from Dr. Jerry Roper, Afton Chemical, providing response to EPA's December 23, 2008 Comments on Manganese pharmacokinetic (PBPK) Gestation and Lactation Rat Model | Supporting & Related Material | Letter, Memorandum, Email | 2009-06-19T04:00:00Z | 2009 | 6 | 2009-06-19T19:42:45Z | 0 | 0 | 09000064809d27c5 | |||
| EPA-HQ-OAR-2004-0074-0216 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Manuscript to be Submitted for Publication, Entitled, "Evaluating Placental Transfer and Tissue Concentrations of Manganese in the Pregnant Rat and Fetuses after Inhaltion Exposures with a PBPK Model | Supporting & Related Material | Publication - Copyrighted Materials | 2009-06-19T04:00:00Z | 2009 | 6 | 2011-10-26T16:58:20Z | 0 | 0 | 09000064809d27c6 | |||
| EPA-HQ-OAR-2004-0074-0217 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Manuscript That Has Been Accepted for Publicaiton Entitled, "Lactational Transfer of Manganese in Rats: Predicting Manganese Tissue Concentration in the Dam and Pups from Inhalation Exposure with a Pharmacokinetic Model | Supporting & Related Material | Publication - Copyrighted Materials | 2009-06-19T04:00:00Z | 2009 | 6 | 2011-10-26T17:04:17Z | 0 | 0 | 09000064809d2e1e | |||
| EPA-HQ-OAR-2004-0074-0218 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Report by Drs. Anderson and Yoon Entitled, Documentation of the Physiologically Based Pharmacokinetic Model for Manganese During Gestation and Lactation in the Rat (3/31/08) | Supporting & Related Material | Report | 2009-06-19T04:00:00Z | 2009 | 6 | 2009-06-19T19:53:01Z | 0 | 0 | 09000064809d2e21 | |||
| EPA-HQ-OAR-2004-0074-0213 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Agenda for 1/29/09 Meeting on Mn PBPK Models (Physiologically Based Pharmacokinetic/ Pharmacodynamic (PBPK/PD) Model) | Supporting & Related Material | Meeting/Teleconference Materials | 2009-02-09T05:00:00Z | 2009 | 2 | 2009-02-09T13:06:54Z | 0 | 0 | 090000648084634c | |||
| EPA-HQ-OAR-2004-0074-0214 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation by Dr. Jerry Roper at 1/29/09 Meeting | Supporting & Related Material | Meeting/Teleconference Materials | 2009-02-09T05:00:00Z | 2009 | 2 | 2009-02-09T13:07:01Z | 0 | 0 | 0900006480846364 | |||
| EPA-HQ-OAR-2004-0074-0212 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation by Dr. Harvey Clewell at the 1/29/09 meeting | Supporting & Related Material | Meeting/Teleconference Materials | 2009-02-05T05:00:00Z | 2009 | 2 | 2009-02-05T15:01:06Z | 0 | 0 | 09000064808463cf | |||
| EPA-HQ-OAR-2004-0074-0211 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation by Dr. Miyoung Yoon at 1/29/09 meeting | Supporting & Related Material | Meeting/Teleconference Materials | 2009-02-05T05:00:00Z | 2009 | 2 | 2009-02-05T15:01:00Z | 0 | 0 | 09000064808463c2 | |||
| EPA-HQ-OAR-2004-0074-0210 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation by Dr. Andy Nong at 1/29/09 meeting | Supporting & Related Material | Meeting/Teleconference Materials | 2009-02-05T05:00:00Z | 2009 | 2 | 2009-02-05T15:00:56Z | 0 | 0 | 09000064808463ae | |||
| EPA-HQ-OAR-2004-0074-0209 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation by Dr. Melvin Andersen during 1/29/09 meeting | Supporting & Related Material | Meeting/Teleconference Materials | 2009-02-05T05:00:00Z | 2009 | 2 | 2009-02-05T15:00:51Z | 0 | 0 | 0900006480846393 | |||
| EPA-HQ-OAR-2004-0074-0208 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Bibliography of Scientific Papers Published From the MMT Alternative Tier 2 (Stage 1) Test Program | Supporting & Related Material | 2009-02-05T05:00:00Z | 2009 | 2 | 2009-02-05T15:00:46Z | 0 | 0 | 090000648084637f | ||||
| EPA-HQ-OAR-2004-0074-0197 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Transmittal Letter for Developmental Mn Physiologically-Based Pharmacokinetic (PBPK) Models (29 August 2008) | Supporting & Related Material | Letter, Memorandum, Email | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:06:49Z | 0 | 0 | 09000064808210ec | |||
| EPA-HQ-OAR-2004-0074-0204 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | USEPA Comments and Approval of Manganese (Mn) Pharmacokinetic (PBPK) Non-Human Primate Model | Supporting & Related Material | Letter, Memorandum, Email | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:07:19Z | 0 | 0 | 09000064808214d2 | |||
| EPA-HQ-OAR-2004-0074-0205 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | USEPA Comments on Manganese (Mn) Physiologically Based Pharmacokinetic Modeling (PBPK) Gestation and Lactation Rat Model | Supporting & Related Material | Letter, Memorandum, Email | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T19:21:07Z | 0 | 0 | 09000064808213b7 | |||
| EPA-HQ-OAR-2004-0074-0206 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Transmittal Letter Providing Additional Documentation on the Physiologically-Based Pharmacokinetic (PBPK) Model for Manganese in Non-Human Primates | Supporting & Related Material | Letter, Memorandum, Email | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T19:21:11Z | 0 | 0 | 09000064808213f6 | |||
| EPA-HQ-OAR-2004-0074-0207 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | A Revised Manuscript on Manganese Physiologically-based Pharmacokinetic (PBPK) Model for Non-human Primates | Supporting & Related Material | Publication - Copyrighted Materials | 2009-01-16T05:00:00Z | 2009 | 1 | 2011-10-26T16:53:42Z | 0 | 0 | 090000648082142d | |||
| EPA-HQ-OAR-2004-0074-0201 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Files Containing Modeling Code for Manganese (Mn) Developmental Models | Supporting & Related Material | Data | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:07:07Z | 0 | 0 | 0900006480821318 | |||
| EPA-HQ-OAR-2004-0074-0199 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | A Hamner Institute Presentation entitled: Manganese Developmental Model for Rats | Supporting & Related Material | Study | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:07:00Z | 0 | 0 | 09000064808211cd | |||
| EPA-HQ-OAR-2004-0074-0200 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Technical Advisory Panel (TAP) Comments on the Developmental Models and Dr. Andersen's Response | Supporting & Related Material | Report | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:07:04Z | 0 | 0 | 09000064808212c2 | |||
| EPA-HQ-OAR-2004-0074-0198 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Manganese Developmental Physiologically-Based Pharmacokinetic (PBPK) Model Report | Supporting & Related Material | Report | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:06:53Z | 0 | 0 | 0900006480821117 | |||
| EPA-HQ-OAR-2004-0074-0202 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Report addressing EPA's May 11, 2001 comments on manganese (Mn) Pharmacokinetic (PBPK) Non-human primate model (27 October 2008) | Supporting & Related Material | Report | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:07:11Z | 0 | 0 | 0900006480821456 | |||
| EPA-HQ-OAR-2004-0074-0203 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Model Code for the Manganese (Mn) Pharmacokinetic (PBPK) Non-Human Primate Model | Supporting & Related Material | Physical Item | 2009-01-16T05:00:00Z | 2009 | 1 | 2009-01-16T18:07:15Z | 0 | 0 | 09000064808214a1 | |||
| EPA-HQ-OAR-2004-0074-0195 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | EPA Comments on Draft Manganese Physiologically-Based Pharamcokinetic Non-human Primate Model | Supporting & Related Material | Letter, Memorandum, Email | 2008-09-23T04:00:00Z | 2008 | 9 | 2008-09-23T13:39:27Z | 0 | 0 | 09000064806f0fe9 | |||
| EPA-HQ-OAR-2004-0074-0191 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Cover Letter transmitting draft PBPK model describing manganese in non-human primates | Supporting & Related Material | Letter, Memorandum, Email | 2008-09-23T04:00:00Z | 2008 | 9 | 2008-09-23T13:39:22Z | 0 | 0 | 09000064806f0f4e | |||
| EPA-HQ-OAR-2004-0074-0192 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | A manuscript describing the draft manganese PBPK models for rat and non-human primates | Supporting & Related Material | Report | 2008-09-23T04:00:00Z | 2008 | 9 | 2008-09-23T13:39:23Z | 0 | 0 | 09000064806f0f77 | |||
| EPA-HQ-OAR-2004-0074-0193 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | The model code in acslXtreme | Supporting & Related Material | Data | 2008-09-23T04:00:00Z | 2008 | 9 | 2008-09-23T13:39:24Z | 0 | 0 | 09000064806f0fab | |||
| EPA-HQ-OAR-2004-0074-0196 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Hamner's transmittal letter to Afton (21 April 2008) | Supporting & Related Material | Letter, Memorandum, Email | 2008-09-23T04:00:00Z | 2008 | 9 | 2008-09-23T15:08:19Z | 0 | 0 | 09000064806f0fd7 | |||
| EPA-HQ-OAR-2004-0074-0194 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Technical Advisory Panel Comments on the draft model | Supporting & Related Material | Report | 2008-09-23T04:00:00Z | 2008 | 9 | 2008-09-23T13:39:25Z | 0 | 0 | 09000064806f0fbd | |||
| EPA-HQ-OAR-2004-0074-0190 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Technical Advisory Plan (TAP) Presentation Slides on Manganese Physiologically Based Pharmacokinetic (PBPK) model in the rat | Supporting & Related Material | Publication - Copyrighted Materials | 2008-06-16T04:00:00Z | 2008 | 6 | 2011-10-26T16:49:17Z | 0 | 0 | 0900006480614f86 | |||
| EPA-HQ-OAR-2004-0074-0188 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Technical Advisory Plan (TAP) Presentation Slides on Manganese Physiologically Based Pharmacokinetic (PBPK) Model in the rat | Supporting & Related Material | Report | 2008-06-10T04:00:00Z | 2008 | 6 | 2008-06-10T16:20:20Z | 0 | 0 | 0900006480614fca | |||
| EPA-HQ-OAR-2004-0074-0189 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation Slides presented by the Hamner Institute for Health Sciences to Afton and USEPA Staff during March 11, 2008 Scientific Meeting | Supporting & Related Material | Report | 2008-06-10T04:00:00Z | 2008 | 6 | 2008-06-10T16:20:20Z | 0 | 0 | 0900006480615033 | |||
| EPA-HQ-OAR-2004-0074-0187 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Technical Advisory Plan (TAP) Presentation Slides on Manganese Physiologically Based Pharmacokinetic (PBPK) Model in the rats and monkeys | Supporting & Related Material | Report | 2008-06-10T04:00:00Z | 2008 | 6 | 2008-06-10T16:20:19Z | 0 | 0 | 0900006480614f63 | |||
| EPA-HQ-OAR-2004-0074-0184 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | EPA Comments on Draft Manganese Physiologically-Based Pharmacokinetic Rat Model | Supporting & Related Material | Letter, Memorandum, Email | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T15:46:22Z | 0 | 0 | 09000064806150a8 | |||
| EPA-HQ-OAR-2004-0074-0186 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Technical Advisory Plan (TAP) Presentation Slides on Manganese Physiologically Based Pharmacokinetic (PBPK) Model in the rat | Supporting & Related Material | Report | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T18:03:50Z | 0 | 0 | 0900006480614f9f | |||
| EPA-HQ-OAR-2004-0074-0182 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation Slides presented by the Hamner Institute for Health Sciences to Afton and EPA Staff during March 11, 2008 Scientific Meeting | Supporting & Related Material | Report | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T15:46:20Z | 0 | 0 | 090000648061505e | |||
| EPA-HQ-OAR-2004-0074-0181 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Summary Report of the ManganesePhysiologically Based Pharmacokinetic (PBPK) Model by the Hamner Institutes for Health Sciences for the Afton Chemical Corporation | Supporting & Related Material | Report | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T15:46:19Z | 0 | 0 | 0900006480614f18 | |||
| EPA-HQ-OAR-2004-0074-0185 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Technical Advisory Panel (TAP) Comments and Dr. Melvin Andersen's Response for Manganese Physiologically Based Pharmacokinetic (PBPK) Model in the rat | Supporting & Related Material | Letter, Memorandum, Email | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T18:03:49Z | 0 | 0 | 0900006480614f45 | |||
| EPA-HQ-OAR-2004-0074-0183 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Presentation Slides presented by the Hamner Institute for Health Sciences to Afton and EPA Staff during March 11, 2008 Scientific Meeting | Supporting & Related Material | Report | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T15:46:21Z | 0 | 0 | 090000648061507c | |||
| EPA-HQ-OAR-2004-0074-0178 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Cover Letter transmitting Draft Manganese Physiologically-Based Pharmacokinetic (PBPK) model for the rat | Supporting & Related Material | Letter, Memorandum, Email | 2008-06-06T04:00:00Z | 2008 | 6 | 2008-06-06T19:58:41Z | 0 | 0 | 0900006480614e6c | |||
| EPA-HQ-OAR-2004-0074-0180 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Manuscript describing the Draft Manganese model in the rat | Supporting & Related Material | Publication - Copyrighted Materials | 2008-06-06T04:00:00Z | 2008 | 6 | 2011-10-26T16:39:38Z | 0 | 0 | 0900006480614ed9 | |||
| EPA-HQ-OAR-2004-0074-0179 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Letter from The Hamner Institutes for Health Sciences to the Afton Chemical Corporation transmitting the Draft Manganese Physiologically Based Pharmacokinetic (PBPK) Model for the rat | Supporting & Related Material | Letter, Memorandum, Email | 2008-06-06T04:00:00Z | 2008 | 6 | 2008-06-06T19:58:42Z | 0 | 0 | 0900006480614e97 | |||
| EPA-HQ-OAR-2004-0074-0177 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Poster on manganese PBPK models presented by Andy Nong of The Hamner Institutes for Health Sciences at the International Congress of Toxicology | Supporting & Related Material | Fact/Data Sheet | 2007-10-10T04:00:00Z | 2007 | 10 | 2007-10-10T19:55:10Z | 0 | 0 | 09000064802fe517 | |||
| EPA-HQ-OAR-2004-0074-0176 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Update and progress report on manganese PBPK models (10/9/2007) | Supporting & Related Material | Letter, Memorandum, Email | 2007-10-10T04:00:00Z | 2007 | 10 | 2007-10-10T19:55:09Z | 0 | 0 | 09000064802fe507 | |||
| EPA-HQ-OAR-2004-0074-0175 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Manganese (Mn) Technical Advisory Panel Report #2 | Supporting & Related Material | Report | 2007-04-20T04:00:00Z | 2007 | 4 | 2007-04-20T17:19:32Z | 0 | 0 | 0900006480229663 | |||
| EPA-HQ-OAR-2004-0074-0174 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | EPA Memorandum: Draft Manganese Physiologically-Based Pharmacokinetic Rat Models | Supporting & Related Material | Letter, Memorandum, Email | 2007-04-20T04:00:00Z | 2007 | 4 | 2007-04-20T17:19:31Z | 0 | 0 | 0900006480229651 | |||
| EPA-HQ-OAR-2004-0074-0173 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Afton Progress Report | Supporting & Related Material | Letter, Memorandum, Email | 2007-04-20T04:00:00Z | 2007 | 4 | 2007-04-20T17:19:29Z | 0 | 0 | 090000648022963f | |||
| EPA-HQ-OAR-2004-0074-0172 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Technical Advisory Panel Comments | Supporting & Related Material | Letter, Memorandum, Email | 2007-03-12T04:00:00Z | 2007 | 3 | 2007-03-12T12:30:46Z | 0 | 0 | 090000648020a966 | |||
| EPA-HQ-OAR-2004-0074-0171 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Draft Report: PK Modeling of Mn in Brain | Supporting & Related Material | Report | 2007-02-26T05:00:00Z | 2007 | 2 | 2007-02-26T20:14:15Z | 0 | 0 | 090000648020a937 | |||
| EPA-HQ-OAR-2004-0074-0167 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Draft Manganese Olfactory Model | Supporting & Related Material | Report | 2007-02-23T05:00:00Z | 2007 | 2 | 2007-02-23T17:47:12Z | 0 | 0 | 090000648020a930 | |||
| EPA-HQ-OAR-2004-0074-0168 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Draft Report: PBPK Modeling for Mn in Rats | Supporting & Related Material | Report | 2007-02-23T05:00:00Z | 2007 | 2 | 2007-02-23T17:47:13Z | 0 | 0 | 090000648020a949 | |||
| EPA-HQ-OAR-2004-0074-0165 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Transmittal Letter from Afton to EPA regarding first set of draft manganese PBPK models | Supporting & Related Material | Letter, Memorandum, Email | 2007-02-23T05:00:00Z | 2007 | 2 | 2007-02-23T17:46:48Z | 0 | 0 | 090000648020a91e | |||
| EPA-HQ-OAR-2004-0074-0166 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Transmittal Letter from CIIT to Afton | Supporting & Related Material | Letter, Memorandum, Email | 2007-02-23T05:00:00Z | 2007 | 2 | 2007-02-23T17:47:08Z | 0 | 0 | 090000648020a925 | |||
| EPA-HQ-OAR-2004-0074-0169 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Draft Report: Modeling Dose Route Differences in Hepatic Mn Extraction | Supporting & Related Material | Report | 2007-02-23T05:00:00Z | 2007 | 2 | 2007-02-23T17:47:14Z | 0 | 0 | 090000648020a955 | |||
| EPA-HQ-OAR-2004-0074-0170 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Draft Report: Compartmental PK Modeling of Manganese Kinetics | Supporting & Related Material | Report | 2007-02-23T05:00:00Z | 2007 | 2 | 2007-02-23T17:47:17Z | 0 | 0 | 090000648020a95c | |||
| EPA-HQ-OAR-2004-0074-0163 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Email transmitting ORD comments on 10/31/2005 Draft Final MMT Emission Characterization Report to Afton | Supporting & Related Material | Letter, Memorandum, Email | 2006-04-03T04:00:00Z | 2006 | 4 | 2006-09-02T15:38:30Z | 0 | 0 | 0900006480146c0f | |||
| EPA-HQ-OAR-2004-0074-0164 | EPA | Methylcyclopentadienyl Manganese Tricarbonyl (MMT) Alternative Tier 2 Health Effects Test Program Legacy Docket ID #: A-98-35 EPA-HQ-OAR-2004-0074 | Final Report entitled, "A Report of the Results of Alternative Tier 2 Testing for the Characterization of Particulate from Vehicles Using the Gasoline Additive MMT in the Fuel | Supporting & Related Material | Report | 2006-04-03T04:00:00Z | 2006 | 4 | 2006-09-02T15:38:30Z | 0 | 0 | 0900006480146c49 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);